InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Ford Robert B, Chairman & CEO. Officer active across 1 companies, notably Abbott Laboratories. Cumulatively, 5 disclosures have been published. The latest transaction was disclosed on 25 March 2022 — Don. Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
033,414 shares0
Common shares without par value
SEC:0001415889-22-003603:0·
€3m26,579 shares@ €109.47980.0013% mcap100.0% of flow
Common shares without par value
SEC:0001415889-22-002191:0·
073,992 shares0
Common shares without par value
SEC:0001415889-22-001735:0·
028,746 shares0
Common shares without par value
SEC:0001415889-21-003428·
028,746 shares0
Common shares without par value
SEC:0001415889-21-003428:0·
5 of 5 declarations
About Ford Robert B
Robert B. Ford is the President and CEO of Abbott Laboratories. He leads the company in its global operations, focusing on innovation and growth. His leadership is essential in maintaining Abbott's position as a leader in the healthcare sector.
